Driven by science and crossdisciplinarity we develop a new drug for the treatment of obesity. In two clinical trials we have demonstratet that EMP16 is safe and effective, and we are in the stage to enter late stage clinical development. Our innovative drug product is based on hands on experience of what actually works for patients, together with in formulation and nutritional expertise.